TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
VTRS

Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

17.80$ +2.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 382 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow VTRS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
834 479 615 379 827 483 536 220 745 816 388 382 2,331
679 644 691 786 670 746 665 678 689 767 676 672 2,804
43 56 47 35 32 32 55 37 36 49 48 39 172
-185 – – – – – – – – – – – –
8.3 -277 -187 -215 139 155 -222 -982 126 -1,426 -703 -347 -2,350
102 201 51 59 85 153 76 54 100 265 40 53 458
-54 116 -154 376 1,748 -169 -65 -53 -99 -211 277 -52 -84
144 144 143 146 143 143 143 140 140 138 140 140 558
-2.6 0.3 -250 -3.4 3.4 0.0 -175 -175 -65 -85 0.0 -150 -300
-23 – – – -1,536 -1,376 1.4 0.0 0.3 -1.6 0.0 -922 -924
-98 -926 -426 -848 -1,637 -1,420 -467 -362 -228 -236 -204 -1,243 -1,911
680 -318 22 -97 962 -1,144 20 -189 436 345 456 -914 322
732 279 564 320 741 329 459 166 645 551 348 329 1,873

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?